Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival
Charles H. Danan, Kaitlyn E. Naughton, Katharina E. Hayer, Sangeevan Vellappan, Emily A. McMillan, Yusen Zhou, Rina Matsuda, Shaneice K. Nettleford, Kay Katada, Louis R. Parham, Xianghui Ma, Afrah Chowdhury, Benjamin J. Wilkins, Premal Shah, Matthew D. Weitzman, Kathryn E. Hamilton
Charles H. Danan, Kaitlyn E. Naughton, Katharina E. Hayer, Sangeevan Vellappan, Emily A. McMillan, Yusen Zhou, Rina Matsuda, Shaneice K. Nettleford, Kay Katada, Louis R. Parham, Xianghui Ma, Afrah Chowdhury, Benjamin J. Wilkins, Premal Shah, Matthew D. Weitzman, Kathryn E. Hamilton
View: Text | PDF
Research Article Gastroenterology

Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival

  • Text
  • PDF
Abstract

Intestinal epithelial transit-amplifying cells are essential stem progenitors required for intestinal homeostasis, but their rapid proliferation renders them vulnerable to DNA damage from radiation and chemotherapy. Despite these cells’ critical roles in intestinal homeostasis and disease, few studies have described genes that are essential to transit-amplifying cell function. We report that RNA methyltransferase-like 3 (METTL3) is required for survival of transit-amplifying cells in the murine small intestine. Transit-amplifying cell death after METTL3 deletion was associated with crypt and villus atrophy, loss of absorptive enterocytes, and uniform wasting and death in METTL3-depleted mice. Sequencing of polysome-bound and methylated RNAs in enteroids and in vivo demonstrated decreased translation of hundreds of methylated transcripts after METTL3 deletion, particularly transcripts involved in growth factor signal transduction such as Kras. Further investigation verified a relationship between METTL3 and Kras methylation and protein levels in vivo. Our study identifies METTL3 as an essential factor supporting the homeostasis of small intestinal tissue via direct maintenance of transit-amplifying cell survival. We highlight the crucial role of RNA modifications in regulating growth factor signaling in the intestine with important implications for both homeostatic tissue renewal and epithelial regeneration.

Authors

Charles H. Danan, Kaitlyn E. Naughton, Katharina E. Hayer, Sangeevan Vellappan, Emily A. McMillan, Yusen Zhou, Rina Matsuda, Shaneice K. Nettleford, Kay Katada, Louis R. Parham, Xianghui Ma, Afrah Chowdhury, Benjamin J. Wilkins, Premal Shah, Matthew D. Weitzman, Kathryn E. Hamilton

×

Figure 6

METTL3 deletion leads to a global decrease in mRNA TE with impacts on growth factor signaling.

Options: View larger image (or click on image) Download as PowerPoint
METTL3 deletion leads to a global decrease in mRNA TE with impacts on gr...
(A) Volcano plot of all transcripts with log2 fold-change in TE > 0.5 or < –0.5 and –log10 P > 1. Red marks all transcripts with increased TE, and blue marks all transcripts with decreased TE. (B) Volcano plot of all transcripts displayed in A, now filtered for transcripts containing at least 1 m6A peak. (C) Pathway enrichment analysis comparing transcripts with downregulated TE (log2FC < –1) and at least 1 m6A peak against Gene Ontology Biological Process (GOBP) gene sets. Circle color and size both scale with number of genes overlapping between the tested gene set and the GOBP gene set. (D) Heatmap depicting z scores for TE. Genes presented are all 42 unique genes from the 4 most significantly enriched pathways in C. Genes are presented in order of greatest decrease in mean TE to smallest decrease. All data from RNA-Seq and polysome-Seq in n = 3 Mettl3fl/fl (CTRL) and n = 3 Mettl3VilCreERΔ/Δ (KO) ileal enteroids 72 hours after initiation of 4-OHT treatment.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts